Glycoprotein Ibα inhibitor (CCP-224) prevents neutrophil-platelet aggregation in sickle cell disease

CCP-224 attenuates neutrophil-platelet aggregation in SCD patient blood. CCP-224 has the potential to prevent vaso-occlusion in SCD patients.

Shranjeno v:
Bibliografske podrobnosti
izdano v:Blood Adv
Main Authors: Jimenez, Maritza A., Novelli, Enrico M., Shaw, Gray D., Sundd, Prithu
Format: Artigo
Jezik:Inglês
Izdano: American Society of Hematology 2017
Teme:
Stimulus Report
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5617353/
https://ncbi.nlm.nih.gov/pubmed/28966995
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2017006742
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki